AMYLIN PHARMACEUTICALS INC (AMLN)
Symbol Info
Listed Symbol AMLN
Name AMYLIN PHARMACEUTICALS INC
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2011-12-01
Latest Fiscal Revenue $650,678,000
Latest Fiscal EPS $-3.73
Price Info
21 Day Moving Average $30.9500
21 Day EMA $30.864520
50 Day Moving Average $30.1894
50 Day EMA $29.897460
200 Day EMA $23.214250
200 Day Moving Average 20.896330
52 Week High $31.02
52 Week Low $8.03
52 Week Change $195.047600
Alpha 0.009222
Beta 1.6563
Standard Deviation 0.187986
R2 0.238265
Periods 60
Share Information
10 Day Average Volume -
20 Day Average Volume 1,358,697
30 Day Average Volume 2,009,342
50 Day Average Volume 5,322,428
Outstanding Shares 164,283,038
Float Shares 164,283,038
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 299
Institute Holdings Date 2012-07-01
Institute Bought Previous 3 Months 67,518,661
Institute Holdings Percent 92.200000
Institute Sold Previous 3 Months 25,649,312
Insider Holdings Date 2012-06-01
Insider Bought Previous 3 Months 45,000
Insider Holdings Percent 1.50%
Insider Sold Previous 3 Months 8,548
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.0299988
21 Day Percent Change 0.10%
30 Day Price Change $0.1499996
30 Day Percent Change 0.49%
Month To Date Price Change $0.1900
Month To Date Percent 0.62%
90 Day Price Change $5.180000
90 Day Percent Change 20.08%
Quarter To Date $2.779999
Quarter To Date Percent 9.86%
180 Day Price Change $12.990000
180 Day Percent Change 72.21%
200 Day Price Change $14.299999
200 Day Percent Change 85.73%
Year To Date $19.599998
Year To Date Percent 172.23%
Profile
Description
Details
Issue Type CS
Market Cap $5,089,488,517
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding -
CEO Daniel M. Bradbury
Employees 1,300
Last Audit UQ
Classification
CIK 0000881464
Industry
Sector
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 9360 Towne Centre Drive
San Diego, CA 92121
Website www.amylin.com
Facisimile (858) 552-2212
Telephone (858) 552-2200
Email michael.york@amylin.com
Key Ratios
Profitability
EBIT Margin -78.9
EBITDA Margin -0.4
Pre-Tax Profit Margin -39.4
Profit Margin Cont -97.7
Gross Margin 94.60
Profit Margin TOT -97.7
Income Statements
Revenue $662,912,000
Revenue Per Share $4.0352
Revenue 3 Years $-5.99
Revenue 5 Years $-3.26
Valuation Measures
PE Ratio -
Enterprise Value $-
Price To Sales 7.677473
Price To Free Cash -59.2
PE High Last 5 Years -
Price To Book -
Price To Cash Flow -8.9
PE Low Last 5 Years -
Price To Tangible Book -16.9
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 1.9
Leverage Ratio -
Quick Ratio 1.3
Long Term Debt To Capital 1.03
Assets
Receivables Turnover 11.1
Invoice Turnover 0.30
Assets Turnover 0.40
Management Effectiveness
Return Assets -32.4
Return On Equity -
Return On Capital -39.4
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
AMLN
Amylin Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.